Mycobacterium avium Complex
"Mycobacterium avium Complex" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A complex that includes several strains of M. avium. M. intracellulare is not easily distinguished from M. avium and therefore is included in the complex. These organisms are most frequently found in pulmonary secretions from persons with a tuberculous-like mycobacteriosis. Strains of this complex have also been associated with childhood lymphadenitis and AIDS; M. avium alone causes tuberculosis in a variety of birds and other animals, including pigs.
Descriptor ID |
D015269
|
MeSH Number(s) |
B03.510.024.049.525.500.720.100 B03.510.460.400.410.552.552.720.100
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Mycobacterium avium Complex".
Below are MeSH descriptors whose meaning is more specific than "Mycobacterium avium Complex".
This graph shows the total number of publications written about "Mycobacterium avium Complex" by people in this website by year, and whether "Mycobacterium avium Complex" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2012 | 1 | 0 | 1 |
2017 | 9 | 7 | 16 |
2018 | 9 | 4 | 13 |
2019 | 2 | 1 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Mycobacterium avium Complex" by people in Profiles.
-
Moxifloxacin resistance and genotyping of Mycobacterium avium and Mycobacterium intracellulare isolates in Japan. J Infect Chemother. 2019 Dec; 25(12):995-1000.
-
Laboratory diagnosis of nontuberculous mycobacteria in a Belgium Hospital. Int J Mycobacteriol. 2019 Apr-Jun; 8(2):157-161.
-
Role of Mycobacterium avium lysate INF-?, IL-17, and IL-2 ELISPOT assays in diagnosing nontuberculous mycobacteria lymphadenitis in children. Eur J Clin Microbiol Infect Dis. 2019 Jun; 38(6):1113-1122.
-
Amikacin Liposome Inhalation Suspension for Treatment-Refractory Lung Disease Caused by Mycobacterium avium Complex (CONVERT). A Prospective, Open-Label, Randomized Study. Am J Respir Crit Care Med. 2018 12 15; 198(12):1559-1569.
-
Mycobacterium avium complex infection in patients with human immunodeficiency virus: A systematic review and meta-analysis. J Cell Physiol. 2019 07; 234(7):9994-10001.
-
Bronchoscopy as a Useful Examination for Determining Surgical Treatment Indications in Refractory Mycobacterium avium Complex Lung Disease Patients with Bilateral Lesions. Intern Med. 2019 Apr 01; 58(7):973-978.
-
Clinical characteristics and early outcomes of patients newly diagnosed with pulmonary Mycobacterium avium complex disease. Respir Investig. 2019 Jan; 57(1):54-59.
-
In Vitro MIC Values of Rifampin and Ethambutol and Treatment Outcome in Mycobacterium avium Complex Lung Disease. Antimicrob Agents Chemother. 2018 10; 62(10).
-
Perfusion Defect-Concordant Progression of Unilateral Refractory Pulmonary Mycobacterium avium Complex Disease. Am J Respir Crit Care Med. 2018 09 15; 198(6):803-804.
-
Efficacy and safety of intermittent maintenance therapy after successful treatment of Mycobacterium avium complex lung disease. J Infect Chemother. 2019 Mar; 25(3):218-221.